AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.570

-0.020-3.39%

Volume:120.28K

Turnover:67.57K

Market Cap:164.83M

PE:-6.30

High:0.585

Open:0.585

Low:0.550

Close:0.590

52wk High:0.730

52wk Low:0.275

Shares:289.18M

Float Shares:168.89M

Volume Ratio:1.04

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.090

EPS(LYR):-0.090

ROE:-1277.62%

ROA:-135.80%

PB:-54.01

PE(LYR):-6.30

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BUZZ-Australia's Reece Pharmaceuticals rises on research and development deal with US Army

BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement

Recce Pharmaceuticals Enters Into Research Agreement With US Army Institute of Surgical Research

MT Newswires Live

Recce Pharmaceuticals Ltd-Recce Enters Second U.S. Department of Defense R&D Agreement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RCE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"RCE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","market":"AU","secType":"STK","nameCN":"RECCE PHARMACEUTICALS LTD","latestPrice":0.57,"timestamp":1770354720000,"preClose":0.59,"halted":0,"volume":120275,"delay":0,"changeRate":-0.0338983050847458,"nameEN":"RECCE PHARMACEUTICALS LTD","floatShares":168893037,"shares":289183422,"eps":-0.090423,"marketStatus":"Market Closed","change":-0.02,"latestTime":"02-06 16:12:00 AEDT","open":0.585,"high":0.585,"low":0.55,"amount":67571,"amplitude":0.059322,"askPrice":0.585,"askSize":1711,"bidPrice":0.575,"bidSize":4827,"shortable":3,"etf":0,"ttmEps":-0.090423,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.59,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":1.0440973224119434,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","floatShares":168893037,"roa":"-135.80%","roe":"-1277.62%","lyrEps":-0.090423,"volumeRatio":1.0440973224119434,"shares":289183422,"dividePrice":0,"high":0.585,"amplitude":0.059322,"preClose":0.59,"low":0.55,"week52Low":0.275,"pbRate":"-54.01","psRate":"21.95","week52High":0.73,"institutionHeld":0,"latestPrice":0.57,"committee":0.476598,"eps":-0.090423,"divideRate":0,"volume":120275,"delay":0,"ttmEps":-0.090423,"open":0.585,"prevYearClose":0.65,"prevWeekClose":0.56,"prevMonthClose":0.56,"prevQuarterClose":0.65,"fiveDayClose":0.56,"twentyDayClose":0.67,"sixtyDayClose":0.425,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-04-15","symbol":"RCE.AU","defaultRemindTime":1744675200000,"type":"split","dateTimestamp":1744639200000,"forFactor":990476,"toFactor":1000000,"ratio":0.990476}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RCE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608883145","title":"BUZZ-Australia's Reece Pharmaceuticals rises on research and development deal with US Army","url":"https://stock-news.laohu8.com/highlight/detail?id=2608883145","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608883145?lang=en_us&edition=fundamental","pubTime":"2026-02-02 12:14","pubTimestamp":1770005675,"startTime":"0","endTime":"0","summary":"BUZZ-Australia'sReece Pharmaceuticals rises on research and development deal with US Army** Shares of Australia's Recce Pharmaceuticals RCE.AX rise as much as 8.9% to A$0.61 ** Stock on track for its best session since December 3, 2025, if gains hold** Stock saps a four-session losing streak, and last up 3.6%** The pharmaceutical co signs a second cooperative research and development agreement with the U.S. Army Institute of Surgical Research** Agreement to conduct study to evaluate effectiveness of RECCE 327 gel in reducing bioburden burn wounds** Stock is down 10.8%, YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nL6N3YY09C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCE.AU","BK7096"],"gpt_icon":0},{"id":"2608833153","title":"BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608833153","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608833153?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:56","pubTimestamp":1769997414,"startTime":"0","endTime":"0","summary":"BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development AgreementFeb 2  - Recce Pharmaceuticals Ltd RCE.AX:RECCE ENTERS SECOND U.S. DEPARTMENT OF DEFENSE RESEARCH AND DEVELOPMENT AGREEMENTAGREEMENT TO ADVANCE RECCE 327 GEL FOR BURN WOUNDSFurther company coverage: RCE.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUE8F1KGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCE.AU","BK7096"],"gpt_icon":0},{"id":"2608882648","title":"Recce Pharmaceuticals Enters Into Research Agreement With US Army Institute of Surgical Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2608882648","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608882648?lang=en_us&edition=fundamental","pubTime":"2026-02-02 07:06","pubTimestamp":1769987208,"startTime":"0","endTime":"0","summary":"Recce Pharmaceuticals  entered into a cooperative research and development agreement with the United States Army Institute of Surgical Research to evaluate its RECCE 327 gel therapy candidate in their validated Walker-Mason rat model of burn wound infection, according to a Monday Australian bourse filing.The study will evaluate whether the gel can significantly reduce bacterial burden in infected burn wounds against methicillin-resistant bacterial pathogens, Staphylococcus aureus and Pseudomonas aeruginosa.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RCE.AU","BK7096"],"gpt_icon":0},{"id":"2608884999","title":"Recce Pharmaceuticals Ltd-Recce Enters Second U.S. Department of Defense R&D Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608884999?lang=en_us&edition=fundamental","pubTime":"2026-02-02 05:58","pubTimestamp":1769983121,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nTUE8F1KGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RCE.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RCE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}